Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma

Steven P. Treon, Evdoxia Hatjiharissi, Giampaolo Merlini

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Waldenström's macroglobulinemia (WM) is a distinct clinicopathological entity resulting from the accumulation, predominantly in the bone marrow, of clonally related lymphocytes, lymphoplasmacytic cells, and plasma cells that secrete a monoclonal IgM protein (Figure 9.1) (1). This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the Revised European American Lymphoma (REAL) and World Health Organization (WHO) classification systems (2, 3). Most cases of LPL are WM, with less than 5% of cases made up of IgA, IgG, and nonsecreting LPL.

Original languageEnglish
Title of host publicationRare Hematological Malignancies
PublisherSpringer US
Pages211-242
Number of pages32
ISBN (Print)9780387737430
DOIs
Publication statusPublished - 2008

Fingerprint

Lymphoma
Waldenstrom Macroglobulinemia
Plasma Cells
Immunoglobulin A
Immunoglobulin M
Immunoglobulin G
Bone Marrow
Lymphocytes
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treon, S. P., Hatjiharissi, E., & Merlini, G. (2008). Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma. In Rare Hematological Malignancies (pp. 211-242). Springer US. https://doi.org/10.1007/978-0-387-73744-7_9

Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma. / Treon, Steven P.; Hatjiharissi, Evdoxia; Merlini, Giampaolo.

Rare Hematological Malignancies. Springer US, 2008. p. 211-242.

Research output: Chapter in Book/Report/Conference proceedingChapter

Treon, SP, Hatjiharissi, E & Merlini, G 2008, Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma. in Rare Hematological Malignancies. Springer US, pp. 211-242. https://doi.org/10.1007/978-0-387-73744-7_9
Treon SP, Hatjiharissi E, Merlini G. Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma. In Rare Hematological Malignancies. Springer US. 2008. p. 211-242 https://doi.org/10.1007/978-0-387-73744-7_9
Treon, Steven P. ; Hatjiharissi, Evdoxia ; Merlini, Giampaolo. / Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma. Rare Hematological Malignancies. Springer US, 2008. pp. 211-242
@inbook{d1a2fd28b0ea4f128ce26181bf7812aa,
title = "Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma",
abstract = "Waldenstr{\"o}m's macroglobulinemia (WM) is a distinct clinicopathological entity resulting from the accumulation, predominantly in the bone marrow, of clonally related lymphocytes, lymphoplasmacytic cells, and plasma cells that secrete a monoclonal IgM protein (Figure 9.1) (1). This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the Revised European American Lymphoma (REAL) and World Health Organization (WHO) classification systems (2, 3). Most cases of LPL are WM, with less than 5{\%} of cases made up of IgA, IgG, and nonsecreting LPL.",
author = "Treon, {Steven P.} and Evdoxia Hatjiharissi and Giampaolo Merlini",
year = "2008",
doi = "10.1007/978-0-387-73744-7_9",
language = "English",
isbn = "9780387737430",
pages = "211--242",
booktitle = "Rare Hematological Malignancies",
publisher = "Springer US",

}

TY - CHAP

T1 - Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma

AU - Treon, Steven P.

AU - Hatjiharissi, Evdoxia

AU - Merlini, Giampaolo

PY - 2008

Y1 - 2008

N2 - Waldenström's macroglobulinemia (WM) is a distinct clinicopathological entity resulting from the accumulation, predominantly in the bone marrow, of clonally related lymphocytes, lymphoplasmacytic cells, and plasma cells that secrete a monoclonal IgM protein (Figure 9.1) (1). This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the Revised European American Lymphoma (REAL) and World Health Organization (WHO) classification systems (2, 3). Most cases of LPL are WM, with less than 5% of cases made up of IgA, IgG, and nonsecreting LPL.

AB - Waldenström's macroglobulinemia (WM) is a distinct clinicopathological entity resulting from the accumulation, predominantly in the bone marrow, of clonally related lymphocytes, lymphoplasmacytic cells, and plasma cells that secrete a monoclonal IgM protein (Figure 9.1) (1). This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the Revised European American Lymphoma (REAL) and World Health Organization (WHO) classification systems (2, 3). Most cases of LPL are WM, with less than 5% of cases made up of IgA, IgG, and nonsecreting LPL.

UR - http://www.scopus.com/inward/record.url?scp=84892816475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892816475&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-73744-7_9

DO - 10.1007/978-0-387-73744-7_9

M3 - Chapter

SN - 9780387737430

SP - 211

EP - 242

BT - Rare Hematological Malignancies

PB - Springer US

ER -